Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Randomized Experiments01:13

Randomized Experiments

6.9K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
6.9K
Group Design02:01

Group Design

8.9K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
8.9K
Crossover Experiments01:16

Crossover Experiments

2.8K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.8K
Blinding01:11

Blinding

2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
Random Sampling Method01:09

Random Sampling Method

11.0K
Sampling is a technique to select a portion (or subset) of the larger population and study that portion (the sample) to gain information about the population. Data are the result of sampling from a population. The sampling method ensures that samples are drawn without bias and accurately represent the population. Because measuring the entire population in a study is not practical, researchers use samples to represent the population of interest. Among the various sampling methods used by...
11.0K
Odds Ratio01:09

Odds Ratio

123
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
123

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Molecular Profiling for Precision Oncology: Moving Beyond Feasibility and Safety.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

A note on rank-preserving structural failure time models to account for crossover.

Clinical trials (London, England)·2026
Same author

Evaluating the impact of stratification on the power and cross-arm balance of randomized phase 2 clinical trials.

Clinical trials (London, England)·2025
Same author

Accrual Suspensions in Seamless Phase II/III Trials: A Review of NRG Oncology Trials.

JCO oncology advances·2025
Same author

Phase III Evaluation of Treatment Combinations in Three-Arm Trials.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2024
Same author

Design of randomized clinical trials with a binary endpoint: Conditional versus unconditional analyses of a two-by-two table.

Statistics in medicine·2024
Same journal

Advancing the Oncology Data Paradigm: Multisite Expansion of Structured Cancer Data Capture at the Point of Care.

JCO oncology practice·2026
Same journal

Clinical Research in Community Oncology: Advancing Cancer Care Through Localized Clinical Trials.

JCO oncology practice·2026
Same journal

Glucagon-Like Peptide-1 Receptor Agonists in Breast Cancer: Metabolic, Clinical, and Survivorship Implications.

JCO oncology practice·2026
Same journal

Implementation and Patient-Reported Outcomes of an Insurance-Supported Integrative Oncology Symptom Management Program.

JCO oncology practice·2026
Same journal

Implementing Systems-Based Interventions to Improve the Care of Cancer Survivors: Small Steps, Large Challenges.

JCO oncology practice·2026
Same journal

Patient Engagement With an Electronic Patient-Reported Outcomes Tool Evaluating Hospital Discharge Readiness After Cancer Surgery.

JCO oncology practice·2026
查看所有相关文章

相关实验视频

Updated: Jun 21, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K

2对1随机化:很少建议使用.

Boris Freidlin1, Edward L Korn1

  • 1Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.

JCO oncology practice
|July 10, 2024
PubMed
概括
此摘要是机器生成的。

一些瘤学试验使用二比一随机化,将更多的患者分配给实验性治疗. 这篇评论质疑了这种常见的瘤学试验设计的假设有利的风险效益比率.

更多相关视频

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.6K
A Within-Subject Experimental Design using an Object Location Task in Rats
09:28

A Within-Subject Experimental Design using an Object Location Task in Rats

Published on: May 6, 2021

4.5K

相关实验视频

Last Updated: Jun 21, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.6K
A Within-Subject Experimental Design using an Object Location Task in Rats
09:28

A Within-Subject Experimental Design using an Object Location Task in Rats

Published on: May 6, 2021

4.5K

科学领域:

  • 在瘤学瘤学.
  • 临床试验 临床试验
  • 生物统计学 生物统计学

背景情况:

  • 随机临床试验 (RCT) 通常将相同的患者数量分配给治疗组.
  • 一些瘤学试验因使用不平等的分配而偏离,例如二比一随机化,有利于实验臂.

研究的目的:

  • 审查瘤学试验中二比一随机化的常见理由.
  • 批判性地评估这种非标准的随机化方法的风险效益比.

主要方法:

  • 对瘤学临床试验设计现有文献和常见实践的审查.
  • 分析二对一随机化对风险效益评估的影响.

主要成果:

  • 识别了使用二对一随机化的常见原因.
  • 质疑这种设计本质上提供了有利的风险/收益平衡的假设.

结论:

  • 在瘤学中,二对一随机化的感知优势可能并不总是超过潜在的缺点.
  • 对于使用不平等随机化方案的试验,需要对风险效益比进行进一步的审查.